WHO urges expanded support as systemic health gaps, conflict, and historic underinvestment fuel Ebola surge in Ituri
Original framing: “WHO calls for more support to tackle Ebola outbreak” — Africa News
The two experimental therapeutics—monoclonal antibodies and antiviral small molecules—are backed by phase‑II data, yet their deployment is hampered by cold‑chain constraints and limited local clinical capacity. Robust scientific monitoring must be paired with capacity building to ensure data integrity and equitable access.
The Ebola surge in Ituri is not an isolated virological event but the product of historic underinvestment, extractive economies, and fragile governance structures that marginalise indigenous knowledge and community agency.
By foregrounding cross‑cultural surveillance, regional financing, and integrative treatment approaches, stakeholders can transform emergency aid into sustainable health resilience. Scientific rigor must be paired with cultural humility, while trickster insights remind us that crisis narratives often conceal deeper inequities. Implementing climate‑resilient infrastructure and honoring marginalised voices will break the cycle of reactive responses and build a proactive, equitable health ecosystem for the DRC and its neighbours.